The Trump administration has been a vocal critic of prescription drug prices in the U.S., and has on numerous occasions vilified the pharmaceutical industry as being responsible for high prices.
But what has the Trump administration accomplished on that front?
Recent actions include requiring drugmakers to include list prices in their direct-to-consumer TV ads, as well as a “blueprint” to lower prices proposed last year by the Department of Health and Human Services (HHS).
Read this in-depth report by The Atlantic on Trump’s history with drug prices since taking office by clicking here.
